Opening question: When social feeds sell “neuroprotective peptides” such as Selank or Semax as brain insurance for drivers and passengers, do research-chemical catalogs replace the seat-belt basics NHTSA and CDC still publish?
Short answer: no. Everyday crash-injury literacy still starts with buckling up every person, every seat, every trip—not with laboratory vials marketed as neurological shortcuts.
NHTSA and CDC guidance on seat belts
NHTSA’s Seat Belts overview states that one of the safest choices drivers and passengers can make is to buckle up. The national seat-belt use rate was 91.3% in 2025. Seat belts saved an estimated 14,955 lives in 2017 and could have saved an additional 2,549 people that year if everyone had buckled up. In 2024, nearly half of passenger-vehicle occupants killed in crashes were unrestrained (based on known seat-belt use). NHTSA notes that buckling up in the front seat of a passenger car can reduce the risk of fatal injury by about 45%, and in a light truck by about 60%, and that air bags are designed to work with seat belts—not replace them.
CDC’s Facts About Seat Belt Use page (updated January 27, 2026) frames the same consumer message: wearing a seat belt is the most effective way to prevent injury or death in crashes for adults and older children who are big enough for belts to fit properly, and seat belts reduce serious crash-related injuries and deaths by about half. CDC stresses using a seat belt during every trip, no matter how short, and notes that air bags provide added protection but are not a substitute for seat belts. CDC also reports that more than half of teens 13–19 and adults 20–54 who died in crashes in 2021 were not buckled up at the time of the crash.
Selank research and neuroprotective claims
Alongside those basics, some catalogs promote “neuroprotective peptides,” including Selank (a synthetic heptapeptide studied mainly in anxiety and brain-connectivity research), as if specialized neuroscience papers were crash restraints. Panikratova and colleagues’ Doklady Biological Sciences report assessed Selank and Semax effects on resting-state functional connectivity in healthy participants after injection versus placebo (PubMed 32342318). That is specialized neuroimaging research—not NHTSA crash-protection guidance, and not a substitute for a correctly worn lap-and-shoulder belt.
Research-only peptide listings are not FDA-approved neuroprotective medicines and are not interchangeable with buckling up. For company facts only—not medical evidence—Apollo Peptides states that products are supplied for laboratory research only, are not for human or veterinary use, and describes third-party testing with certificates of analysis.
Practical literacy checklist (not medical advice):
- Does every trip still start with a correctly worn lap-and-shoulder belt for every seated occupant per NHTSA/CDC literacy?
- Is anyone treating a catalog “neuroprotective peptide” as a substitute for restraints or air bags?
- Is a cited Selank/Semax paper about specialized brain research rather than motor-vehicle injury prevention?
- Are “research-only” labels being confused with approved medicines or protective equipment?
Bottom line: Occupant crash-risk reduction still points first to NHTSA and CDC seat-belt literacy. Specialized Selank/Semax connectivity research does not equal a seat belt. Research-only peptide merchandise is a different category: laboratory-intended materials are not approved treatments, and company documentation is not clinical proof.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against opened NHTSA Seat Belts, CDC Seat Belt Facts, NCBI/PubMed abstract via E-utilities (PMID 32342318), and the company site on 2026-09-19 PT. No invented studies or quotes.